PROLIA (DENOSUMAB)


PROLIA (DENOSUMAB)

  • Loss of bone density due to androgen deprivation therapy
  • Osteoporosis in male patient
  • Postmenopausal osteoporosis and high fracture risk
  • Glucocorticoid-induced osteoporosis
  • Loss of bone density due to aromatase inhibitor therapy